Lungenärzte am Rundfunkplatz
- Address
- Rundfunkplatz 2, 80335 Lungenärzte am Rundfunkplatz, Germany
Lungenärzte am Rundfunkplatz - Pulmonary Infectious Disease Research
Lungenärzte am Rundfunkplatz is a specialized pulmonary medicine center with expertise in respiratory infectious diseases and advanced inhalation therapy research. The center focuses on challenging pulmonary infections, particularly those caused by difficult-to-treat pathogens in adult patients.
- Nontuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium Complex (MAC)
- Novel inhalation-based antibiotic delivery systems including liposomal formulations
- Patient-reported outcomes and respiratory symptom assessment in chronic lung infections
The center's research portfolio emphasizes innovative treatment approaches for newly diagnosed NTM lung infections, evaluating combination therapies that include Amikacin Liposome Inhalation Suspension (ALIS) alongside standard background regimens with azithromycin and ethambutol. Their clinical trials infrastructure supports comprehensive evaluation of both microbiological outcomes and patient-centered measures, contributing to the advancement of therapeutic options for complex respiratory infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Lungenärzte am Rundfunkplatz
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Amikacin Liposome Inhalation Suspension with Azithromycin and Ethambutol in Adult Patients with MAC-Induced NTM Lung Infection | Insmed Inc. | Phase III | Not Recruiting | Feb 2021 | Dec 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amikacin | 1 | Unknown | 2021-02-15 | 2021-02-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.